Table I.
Characteristics | MRSA (+) | MRSA (−)* |
---|---|---|
Patient N (% total N) | 11 (21) | 41 (79) |
Median age (IQR) | 36 yrs (32 – 44) | 35 yrs (28 – 44) |
Sex | ||
Female (%) | 6 (55) | 18 (44) |
Male (%) | 5 (45) | 23 (56) |
Hospitalised last 2 yrs (%) | 9 (82)† | 17 (41) |
On TB treatment (%) | 11 (100) | 41 (100) |
HIV status | ||
Positive (%) | 9 (82) | 35 (85) |
Negative | 1 (9) | 1 (3) |
Unknown | 1 (9) | 5 (12) |
Median CD4 count (IQR) | 37 cells/mm3 (20 – 60)‡ | 127 cells/mm3 (47 – 190) |
Receiving cotrimoxazole (% of HIV-infected) | 7 (64) | 24 (59) |
Four (10%) additional patients who were initially negative for MRSA had a positive follow-up culture.
p=0.08.
Available in 41 (93%) HIV-infected patients, p=0.03. No other clinical characteristics were significantly different on admission.
IQR = interquartile range.